MX2012003612A - Bifidobacterium longum atcc baa-99 (bl999) y control de peso. - Google Patents

Bifidobacterium longum atcc baa-99 (bl999) y control de peso.

Info

Publication number
MX2012003612A
MX2012003612A MX2012003612A MX2012003612A MX2012003612A MX 2012003612 A MX2012003612 A MX 2012003612A MX 2012003612 A MX2012003612 A MX 2012003612A MX 2012003612 A MX2012003612 A MX 2012003612A MX 2012003612 A MX2012003612 A MX 2012003612A
Authority
MX
Mexico
Prior art keywords
bifidobacterium longum
atcc baa
longum atcc
weight control
present
Prior art date
Application number
MX2012003612A
Other languages
English (en)
Spanish (es)
Inventor
Gabriela Bergonzelli De Gonda
Stephen Michael Collins
Premysl Bercik
Elena Verdu De Bercik
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41683555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012003612(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2012003612A publication Critical patent/MX2012003612A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2012003612A 2009-09-30 2010-09-28 Bifidobacterium longum atcc baa-99 (bl999) y control de peso. MX2012003612A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09171866A EP2308499A1 (en) 2009-09-30 2009-09-30 Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
PCT/EP2010/064348 WO2011039176A1 (en) 2009-09-30 2010-09-28 Bifidobacterium longum atcc baa-999 (bl999) and weight control

Publications (1)

Publication Number Publication Date
MX2012003612A true MX2012003612A (es) 2012-04-19

Family

ID=41683555

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012003612A MX2012003612A (es) 2009-09-30 2010-09-28 Bifidobacterium longum atcc baa-99 (bl999) y control de peso.

Country Status (15)

Country Link
US (1) US20120244125A1 (enExample)
EP (2) EP2308499A1 (enExample)
JP (1) JP5911424B2 (enExample)
CN (1) CN102665737A (enExample)
AR (1) AR078485A1 (enExample)
AU (1) AU2010303020B2 (enExample)
BR (1) BR112012007109A2 (enExample)
CA (1) CA2775976A1 (enExample)
CL (1) CL2012000809A1 (enExample)
IN (1) IN2012DN02463A (enExample)
MX (1) MX2012003612A (enExample)
PH (1) PH12012500569A1 (enExample)
RU (1) RU2567660C2 (enExample)
SG (1) SG10201406169VA (enExample)
WO (1) WO2011039176A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011114916A1 (ja) * 2010-03-18 2011-09-22 森永乳業株式会社 貧血の予防又は治療用組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
FI20116008A0 (fi) * 2011-10-12 2011-10-12 Maeyrae Maekinen Annika Viskeraalisen rasvan estäminen ja diagnostisointi
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
BR112015020977A2 (pt) 2013-03-08 2017-07-18 Axiom Foods Inc suplemento de proteína de arroz e métodos de uso do mesmo
JP6234331B2 (ja) * 2014-06-13 2017-11-22 森永乳業株式会社 統合失調症治療剤
TWI572713B (zh) * 2014-10-31 2017-03-01 豐華生物科技股份有限公司 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用
JP6650728B2 (ja) * 2015-03-06 2020-02-19 株式会社ファンケル ダイエット用の製剤
EP3386523B1 (en) * 2015-12-11 2019-10-09 Alimentary Health Limited Bifidobacterium longum for treating obesity and associated metabolic disorders
JP6847577B2 (ja) * 2015-12-28 2021-03-24 森永乳業株式会社 ビフィドバクテリウム属細菌および／または乳酸菌の増殖促進および／または減少抑制剤
KR102548553B1 (ko) * 2016-04-14 2023-06-27 듀폰 뉴트리션 바이오사이언시즈 에이피에스 제지방 체중을 증가시키기 위한 비피더스균
IT201600105831A1 (it) * 2016-10-20 2018-04-20 Probiotical Spa Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo
KR101920219B1 (ko) * 2017-03-08 2018-11-20 서울대학교산학협력단 비피더스균을 포함하는 비만 예방 또는 개선용 조성물
EP3634155A4 (en) 2017-05-12 2021-02-17 Axiom Foods Inc. RICE PRODUCTS AND SYSTEMS AND PROCESSES FOR THEIR PRODUCTION
CA3073615A1 (en) 2017-08-25 2019-02-28 University College Cork - National University Of Ireland Cork Bifidobacterium longum for treating obesity and weight management
WO2019087280A1 (ja) * 2017-10-31 2019-05-09 森永乳業株式会社 筋肉増量用組成物
EP3713587B1 (en) 2017-11-24 2024-03-27 University College Cork-National University of Ireland, Cork A composition comprising a cohort of bacteria
CN117701424A (zh) * 2018-04-11 2024-03-15 韩国生命工学研究院 具有肥胖预防或治疗效果的新的鼠李糖乳杆菌菌株及其用途
CN111187734A (zh) * 2019-12-25 2020-05-22 生合生物科技（扬州）有限公司 长双歧杆菌bl986、由其制备的冻干粉及冻干粉的应用
JP7475155B2 (ja) * 2020-02-14 2024-04-26 森永乳業株式会社 持久力向上用組成物
WO2021233925A1 (en) * 2020-05-20 2021-11-25 Société des Produits Nestlé S.A. Beneficial effect of poaceae and/or leguminoseae fiber on survivability and metabolic activity of bifidobacterium longum
EP4070670A1 (en) 2021-04-08 2022-10-12 University College Cork-National University of Ireland Cork Lacticaseibacillus paracasei em025-11 and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61109729A (ja) * 1984-11-05 1986-05-28 Advance Res & Dev Co Ltd コレステロ−ル低下剤
JP2687229B2 (ja) * 1988-11-11 1997-12-08 株式会社ヤクルト本社 血圧降下剤
JP4280016B2 (ja) * 2002-02-28 2009-06-17 雪印乳業株式会社 糖尿病合併症予防・改善・治療剤
JP2003252771A (ja) * 2002-03-04 2003-09-10 Snow Brand Milk Prod Co Ltd 加齢に伴う代謝異常疾患の予防・改善・治療剤
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
JP2007169200A (ja) * 2005-12-21 2007-07-05 Morinaga Milk Ind Co Ltd インフルエンザ感染予防のための医薬及び飲食品
RU2008134892A (ru) * 2006-01-27 2010-03-10 Даниско А/С (Dk) Применение пробиотичеких микроорганизмов для лечения и профилактики ожирения и связанных с ним расстройств
ES2381211T3 (es) * 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
EP2002842B1 (en) * 2006-03-31 2012-04-11 Morinaga Milk Industry Co., Ltd. Method for production of the interleukin production regulator
KR20080075971A (ko) * 2007-02-14 2008-08-20 (주)네오팜 프로바이오틱스 복합 제제
EP1974734A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
UA30077U (uk) * 2007-10-18 2008-02-11 Одесская Национальная Академия Пищевых Технологий Композиція для йогурту діабетичного призначення
UA31009U (uk) * 2007-10-18 2008-03-25 Одесская Национальная Академия Пищевых Технологий Кисломолочний напій діабетичного призначення
JP2009143820A (ja) * 2007-12-12 2009-07-02 Tsujido Chemical Corp 高尿酸血症の予防または改善剤

Also Published As

Publication number Publication date
CL2012000809A1 (es) 2012-07-13
RU2567660C2 (ru) 2015-11-10
AU2010303020B2 (en) 2014-11-20
BR112012007109A2 (pt) 2016-07-05
US20120244125A1 (en) 2012-09-27
RU2012117804A (ru) 2013-11-20
SG10201406169VA (en) 2014-11-27
AU2010303020A1 (en) 2012-04-19
EP2308499A1 (en) 2011-04-13
PH12012500569A1 (en) 2012-10-22
JP2013506631A (ja) 2013-02-28
CN102665737A (zh) 2012-09-12
IN2012DN02463A (enExample) 2015-05-22
EP2482829A1 (en) 2012-08-08
AR078485A1 (es) 2011-11-09
JP5911424B2 (ja) 2016-04-27
WO2011039176A1 (en) 2011-04-07
CA2775976A1 (en) 2011-04-07

Similar Documents

Publication Publication Date Title
MX2012003612A (es) Bifidobacterium longum atcc baa-99 (bl999) y control de peso.
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
EP2405918A4 (en) PREBIOTIC OLIGOSACCHARIDE
TN2011000673A1 (en) Bace inhibitors
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
MX350234B (es) Compuestos de enlace especificos de bacterias gram-positivas.
MX355543B (es) Macrociclos peptidomiméticos.
UA110103C2 (uk) Модифікований туберкульозний антиген
UA109123C2 (uk) Пробіотична композиція для застосування в лікуванні запалення кишечнику
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
MY165273A (en) Anti-cd48 antibodies and uses thereof
MX336001B (es) Anticuerpos anti-axl y metodos de uso.
MX2013001473A (es) Anticuerpos contra il-18r1 y usos de los mismos.
JO3450B1 (ar) أشكال جرعات تحرير جديدة معدلة لمثبطات زانثين اوكسيدوريدوكتيز أو مثبطات زانثين اوكسيديز
PH12012501308A1 (en) Binding members for human cytomegalovirus
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX2012011829A (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
MX2011008398A (es) Lactobacillus helveticus cncm i-4095 y el control del peso.
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
PH12014501061B1 (en) Tricyclic compounds, compositions comprising them and uses thereof
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
MY165075A (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
UY34575A (es) Composiciones y métodos para el tratamiento de diabetes y/u obesidad
MX2012004282A (es) Composiciones farmaceuticas.
WO2010118286A3 (en) Benzimidazole modulators of h1 receptor and/or ns4b protein activity

Legal Events

Date Code Title Description
FA Abandonment or withdrawal